Approval · Notice of Compliance 20010 · 2017
INFLECTRA: Notice of Compliance 20010
Issued November 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20010
- Date
- November 7, 2017
- Company
- Celltrion Healthcare Co Ltd
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFLECTRA | Not yet assigned | — |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL